UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer

Cancer, 2015-10, Vol.121 (20), p.3737-3745

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

Cancer discovery, 2022-01, Vol.12 (1), p.74-89

2022

Link zum Volltext

Verfügbarkeit prüfen

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2509-2515

2012

Link zum Volltext

Verfügbarkeit prüfen

Interdisciplinary Palliative Care for Patients With Lung Cancer

Journal of pain and symptom management, 2015-12, Vol.50 (6), p.758-767

2015

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-01, Vol.28 (1), p.56-62

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2022-01, Vol.89 (1), p.105-115

2022

Link zum Volltext

Verfügbarkeit prüfen

Understanding Family Caregiver Communication to Provide Family-Centered Cancer Care

Seminars in oncology nursing, 2017-12, Vol.33 (5), p.507-516

2017

Link zum Volltext

Verfügbarkeit prüfen

New Standards and Implications for Improving the Quality of Supportive Oncology Practice

Journal of clinical oncology, 2008-08, Vol.26 (23), p.3824-3831

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical Procedures

The Annals of thoracic surgery, 2016-02, Vol.101 (2), p.495-503

2016

Link zum Volltext

Verfügbarkeit prüfen

Precision medicine and actionable alterations in lung cancer: A single institution experience

PloS one, 2020-02, Vol.15 (2), p.e0228188-e0228188

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2009-01, Vol.4 (1), p.97-101

2009

Link zum Volltext

Verfügbarkeit prüfen

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

Journal of clinical medicine, 2022-03, Vol.11 (5), p.1429

2022

Link zum Volltext

Verfügbarkeit prüfen

Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy

Frontiers in oncology, 2023-02, Vol.13, p.1064169-1064169

2023

Link zum Volltext

Verfügbarkeit prüfen

Cancer Communication and Family Caregiver Quality of Life

Behavioral sciences, 2017-03, Vol.7 (1), p.12

2017

Link zum Volltext

Verfügbarkeit prüfen

Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC

Cancers, 2022-08, Vol.14 (16), p.3983

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ( EGFR )-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

Frontiers in oncology, 2019-03, Vol.9, p.132-132

2019

Link zum Volltext

Verfügbarkeit prüfen

Palliative Care in Lung Cancer

The Surgical clinics of North America, 2011-04, Vol.91 (2), p.403-417

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors

Cancers, 2021-05, Vol.13 (11), p.2653

2021

Link zum Volltext

Verfügbarkeit prüfen

695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A787-A787

2023

Link zum Volltext

Verfügbarkeit prüfen

Reducing Patient Barriers to Pain and Fatigue Management

Journal of pain and symptom management, 2010-03, Vol.39 (3), p.486-501

2010

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Barriers to Cancer Pain Management: An Institutional Change Model

Journal of pain and symptom management, 2007-10, Vol.34 (4), p.359-369

2007

Link zum Volltext

Verfügbarkeit prüfen

Barriers to pain assessment and management in cancer survivorship

Journal of cancer survivorship, 2008-03, Vol.2 (1), p.65-71

2008

Link zum Volltext

Verfügbarkeit prüfen

Palliative Care in the New Era of Lung Cancer Treatment

Journal of hospice and palliative nursing, 2023-06, Vol.25 (3), p.E58

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(158)

Sprache

Englisch
(156)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Life Sciences & Biomedicine
(72)
Humans
(67)
Oncology
(61)
Female
(48)
Male
(42)
Middle Aged
(42)
Aged
(41)
Adult
(30)
Aged, 80 And Over
(25)
Lung Cancer
(21)
Quality Of Life
(18)
Lung Neoplasms - Pathology
(17)
Treatment Outcome
(16)
Lung Neoplasms - Drug Therapy
(15)
Patients
(15)
Lung Neoplasms - Therapy
(14)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(13)
Neoplasm Staging
(13)
Respiratory System
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

Interdisciplinary Palliative Care for Patients With Lung Cancer

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer

Understanding Family Caregiver Communication to Provide Family-Centered Cancer Care

New Standards and Implications for Improving the Quality of Supportive Oncology Practice

Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical Procedures

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

Precision medicine and actionable alterations in lung cancer: A single institution experience

Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy

Cancer Communication and Family Caregiver Quality of Life

Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC

Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ( EGFR )-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

Palliative Care in Lung Cancer

Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON)

Reducing Patient Barriers to Pain and Fatigue Management

Overcoming Barriers to Cancer Pain Management: An Institutional Change Model

Barriers to pain assessment and management in cancer survivorship

Palliative Care in the New Era of Lung Cancer Treatment

Suchergebnisse filtern